Sign in

NCT07177391Recruiting

Discontinuous Echocardiographic Subcostal Cardiac Output Measurement

Discontinuous Echocardiographic Subcostal Cardiac Output Measurement by the Right Ventricular Outflow Tract in Critical Care

Source: ClinicalTrials.gov · Last updated 17 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Cardiac output (CO) monitoring is recommended for the most serious and multiple-failure patients in critical care and allows the diagnosis of acute circulatory failure as well as its etiology and also allows the monitoring of treatments. However, although allowing an adaptation of hemodynamic treatments and being integrated into a therapeutic personalization approach in situations of acute circulatory failure, the measurement of CO is conditioned by the availability of devices, by their sometimes problematic invasiveness, as well as their cost. In addition, the discontinuous measurement of CO by echocardiography is made difficult in the context of resuscitation with patients who are less mobilizable and less echogenic.

Status (registry)
Recruiting
Study type
Observational
Enrollment
50 (estimated)
First submitted
9 Sept 2025
Start date
25 Nov 2024
Primary completion date
9 Sept 2025
Lead sponsor
University Hospital, Rouen
NCT number
NCT07177391

What you commit to

  • Study type: Observational
  • Planned participants: 50
  • From 25 Nov 2024 to the primary completion date, 9 Sept 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Person deprived of liberty by an administrative or judicial decision or person placed under judicial protection/guardianship or curatorship
  • Patient not affiliated with the social security system
  • Refusal by the patient or trusted person if the patient is incapable of expressing consent
  • Pregnant woman
  • Dying patient

Who the study is looking for

  • Adult patient (Age ≥ 18 years)
  • Patient admitted to the intensive care unit at Rouen University Hospital.
  • Transthoracic echocardiography (TTE) is required upon admission or during the patient's stay for diagnostic assessment and/or therapeutic monitoring.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
University Rouen Hospital
Coordinator of this site? Confirm its status
RouenFranceRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.